Video

Dr. Ruan on the Evolving Armamentarium in MCL

Jia Ruan, MD, PhD, discusses the evolving armamentarium ​in mantle cell lymphoma.

Jia Ruan, MD, PhD, associate professor of clinical medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses the evolving armamentarium ​in mantle cell lymphoma (MCL).

Chemoimmunotherapy has been a historical ​treatment approach ​for patients with MCL, says Ruan. However, over the past few years, treatment has evolved to ​incorporate effective, low​-intensity, oral-based strategies, which are being used in the outpatient setting​, Ruan explains. These therapies can be used in induction regimens or as treatment in the relapsed/refractory setting, Ruan says.

This shift has been revolutionary in the field of MCL​, says Ruan. Therapy ​has become more convenient and accessible for ​the majority of patients, regardless of age and comorbidities.

This treatment approach will ​hopefully continue to benefit patients ​by extending remission duration and improving survival outcome for many years to come, Ruan concludes.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies
Audio

Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies

Jun 18th 2025 - Jun 19th 2026

online-activity
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity